CLINICAL_TRIALS
research
· 2011-08-04
Clinical Trial Update: Prospective Donor Specific Antibody (DSA) Monitoring Protocol
Summary
Clinical trial update describing a prospective donor-specific antibody (DSA) monitoring protocol for kidney and kidney/pancreas transplant recipients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Providence Health & Services | Conditions: Kidney Transplant, Kidney/Pancreas Transplant | Status: UNKNOWN